Assertio Holdings, Inc. (ASRT)
9.19
-0.12
(-1.29%)
USD |
NASDAQ |
Jan 09, 16:00
9.37
+0.18
(+1.96%)
After-Hours: 20:00
Assertio Holdings Research and Development Expense (Annual): 3.822M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics, Inc. | 39.33M |
| Skye Bioscience, Inc. | 18.70M |
| Theravance Biopharma, Inc. | 36.04M |
| Kyntra Bio, Inc. | 95.69M |
| Myomo, Inc. | 4.772M |